RWE Project without limitation of exploration & Research
We design various RWE studies based on EMR data from actual treatment sites and provide environment to create Real World Evidence.
* RWD : Real World Data
RWE & RWE Research Coverage
RWD includes treatment or outcomes experienced by patients in the medical environment and is utilized as evidence to create RWE. RWE helps to evaluate and understand treatment effectiveness, safety, and cost-effectiveness in actual clinical sites.
Key case of clinical research activities
Evaluate effective treatment options
In medical environment, you can evaluate the effectiveness of treatment or drug on specific patient.
Adverse Event and Safety monitoring
You can evaluate the incidence and safety of adverse effects in various treatment processes such as drugs, surgery, and treatments, etc.
Support for new drug development and approval
You can use basis for approval by regulatory authorities with analyzing the effectiveness and safety of a new drug
Healthcare Cost and Economic Analysis
You can use in economic evaluation studies by analyzing treatment cost efficiency, medical resource usage patterns, etc.
RWE research case
We have extensive experiences of providing professional services throughout the entire RWE study process, from RWE research design to data analysis and report submission.
TKI Treatment Patterns in Chronic Myeloid Leukemia Patients: A Retrospective Cohort Study
Target Patients
Having a confirmed diagnosis of CML and at least one TKI prescription during the follow-up period.
Inclusion Criteria
Operational definitions for diagnoses, comorbidities, anticancer therapies, and observation periods
Outcome Measures
Treatment patterns and incidence of adverse events in patients with chronic myeloid leukemia undergoing combination therapy
Comparison of the Effectiveness and Safety of Combination Therapy with Metformin and SGLT-2 Inhibitors or DPP-4 Inhibitors in Patients with Type 2 Diabetes Using EMR Data
Target Patients
Patients diagnosed with type 2 diabetes and prescribed combination therapy with Metformin and either DPP-4 inhibitors or SGLT-2 inhibitors
Inclusion Criteria
Operational definitions for diagnoses, combination therapy settings, and observation periods
Outcome Measures
Improvement rate of HbA1c after combination therapy
Comparison of the Effectiveness and Safety of MPA Formulations for Preventing Gastrointestinal Bleeding in Patients Co-administered Aspirin and Acid Suppressants
Target Patients
Patients prescribed Aspirin/NSAIDs and diagnosed with gastrointestinal bleeding
Inclusion Criteria
Operational definitions for diagnoses, drug exposure settings, and follow-up periods
Outcome Measures
Incidence of gastrointestinal bleeding
Comparison of Cardiovascular Disease Risk Based on NSAID Dosage in Patients with Ankylosing Spondylitis
Target Patients
Patients diagnosed with ankylosing spondylitis and taking nonsteroidal anti-inflammatory drugs (NSAIDs)
Inclusion Criteria
Operational definitions for diagnoses, drug exposure settings, and observation periods
Outcome Measures
Incidence of cardiovascular diseases
Instant and accurate Feasibility Check
Apply for your desired study condition and we will provide you with an estimate of the number of patients and data variables that can be extracted using hospital-specific metadata.
If you have difficulty in planning your research
We can help to establish a feasible research plan by calculating the possibility of recruiting patients, the status of hospitals participating in the study, and the cost, manpower, and time required to conduct the study. After service inquiry, check the simple data count, feasibility check, synopsis, and preliminary analysis results with actual hospital data.
* The screen image is an example created with synthetic data.